HFM Investment Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353 Buy
6
+3
+100% +$126 ﹤0.01% 1094
2026
Q1
$97 Hold
3
– – ﹤0.01% 1122
2025
Q4
$127 Hold
3
– – ﹤0.01% 1128
2025
Q3
$103 Hold
3
– – ﹤0.01% 1151
2025
Q2
$81 Buy
3
+2
+200% +$58 ﹤0.01% 1181
2025
Q1
$30 Buy
+1
New +$38 ﹤0.01% 1119

Other funds holding VCYT

HFM Investment Advisors's VCYT Position: Q2 2026 in Review

HFM Investment Advisors increased its Veracyte (VCYT) stake by 100% in Q2 2026, buying an estimated $126 and bringing the position to 6 shares worth $353. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

HFM Investment Advisors first reported a position in VCYT in Q1 2025 and has held it in 6 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • HFM Investment Advisors held 6 shares of Veracyte worth $353 as of Q2 2026.
  • HFM Investment Advisors bought 3 Veracyte shares in Q2 2026, an estimated $126.
  • Veracyte made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #1094 holding.
  • HFM Investment Advisors first reported a position in Veracyte in Q1 2025 and has held it in 6 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.